Search

Your search keyword '"Ferrari, Gm"' showing total 559 results

Search Constraints

Start Over You searched for: Author "Ferrari, Gm" Remove constraint Author: "Ferrari, Gm"
559 results on '"Ferrari, Gm"'

Search Results

1. Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease

2. Ablation index predicts outcomes of catheter ablation of focal atrial tachycardia: results of a multicenter study

6. Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives [Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici]

7. Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives [Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici]

8. Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION).

9. Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.

11. Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

12. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

13. Evolocumab and clinical outcomes in patients with cardiovascular disease

14. Evolocumab and clinical outcomes in patients with cardiovascular disease

15. Ezetimibe added to statin therapy after acute coronary syndromes

16. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis: First report from the italian registry of pediatric thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili)

17. Response to Letters Regarding Article, 'clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation'

20. Synchronous fluorescence spectra of dissolved organic matter (DOM) of algal origin in marine coastal waters

21. Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry

22. Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment

23. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study

24. Gene symbol: SCN5A. Disease: Brugada syndrome in Novel human pathological mutations

25. Gene Symbol: KCNH2 Disease: Long QT syndrome

26. Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations

27. Gene symbol: KCNQ1. Disease: Long QT syndrome

28. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry

29. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes

30. PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis

31. Torsades de pointes following acute myocardial infarction: Evidence for a deadly link with a common genetic variant.

32. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD

33. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

34. Gene symbol: SCN5A. Disease: Brugada syndrome in Novel human pathological mutations

35. Gene symbol: SCN5A. Disease: Brugada syndrome

36. Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations

37. Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations

38. KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome

39. The organization of the autotransfusion-perioperative blood salvage at San Martino Hospital

44. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.

48. Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: The TG-REAL Retrospective Cohort Analysis

Catalog

Books, media, physical & digital resources